1. <source id="xpzyt"><menu id="xpzyt"></menu></source>

    1. <u id="xpzyt"><address id="xpzyt"><thead id="xpzyt"></thead></address></u>
    2. 
      
      <u id="xpzyt"></u>

      <source id="xpzyt"><menuitem id="xpzyt"></menuitem></source>

      Join Nasal-Phyto Company News Technical Support 中文

      Join Nasal-Phyto Company News Technical Support Chinese

      Categories Of News

      Parkinson's New Drug! Inbrija, the first inhaled levodopa product, launched in the US to treat OFF s

      Author:adminTime:2019/12/5 21:22:33Click:1798

      March 4, 2019 / BIOON /-Biocor Therapeutics has announced the launch of Inbrija (levodopa inhalation powder) in the US market. The drug was approved by the US FDA on December 21, 2018 for use in Intermittent treatment for patients with Parkinson's di····

      Read More

      New drugs that benefit 340 million patients worldwide are expected to be declared for listing next y

      Author:adminTime:2019/12/5 21:19:23Click:1674

      Oyster Point Pharmaceuticals has submitted a NASDAQ listing application to the US Securities and Exchange Commission, and plans to raise $ 85 million in an IPO. This is a biotechnology company dedicated to developing first-in-class therapies for dry ····

      Read More

      The first new mechanism antidepressant in 30 years! Johnson & Johnson Spravato Nasal Spray Submits N

      Author:adminTime:2019/12/5 21:15:38Click:1806

      October 10, 2019 / Bio Valley BIOON /-Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, recently announced that it has submitted a new supplement to the US Food and Drug Administration (FDA) depression drug Spravato (esketamine) CIII nasal spr····

      Read More

      New major depression drug launched! FDA approves new nasal spray formulation with rapid onset of act

      Author:adminTime:2019/12/5 21:14:04Click:1799

      On March 5, local time, the FDA issued a statement saying it agreed to approve the launch of a new nasal spray drug, Spravato (Esketamine), for the treatment of resistant depression. This is the first major depression treatment to enter the US market····

      Read More

      The first new medicine in 20 years! UCB's new epilepsy drug Nayzilam receives FDA approval

      Author:adminTime:2019/11/28 9:52:07Click:1723

      Belgian pharmaceutical company UCB recently announced that the US FDA has approved its latest antiepileptic drug (AED) Nayzilam (midazolam) nasal spray CIV. This is a benzodiazepine drug for nasal administration. It is suitable for the emergency trea····

      Read More

      麻豆无吗一精品一Av一_在线的中文字幕Av_911精品高清影院_国产毛片三级在线

      1. <source id="xpzyt"><menu id="xpzyt"></menu></source>

      1. <u id="xpzyt"><address id="xpzyt"><thead id="xpzyt"></thead></address></u>
      2. 
        
        <u id="xpzyt"></u>

        <source id="xpzyt"><menuitem id="xpzyt"></menuitem></source>